HRAS and cancer: The c.35G>T mutation (p.Gly12Val) in HRAS was the first mutation in a proto-oncogene that was implicated in cancer [2,3] and it is the second most frequently reported HRAS mutation in human cancers (Cosmic database: http://cancer.sanger.ac.uk/cosmic/gene/overview?ln=HRAS).